Enanta Pharmaceuticals Aktie
9,95
EUR
+0,20
EUR
+2,05
%
11,76
USD
+0,26
USD
+2,26
%
Werbung
Enanta Pharmaceuticals Aktie Analyse
| 24.05.19 | Enanta Pharmaceuticals Outperform | Wolfe Research | |
| 02.01.18 | Enanta Pharmaceuticals Sector Perform | RBC Capital Markets | |
| 21.11.17 | Enanta Pharmaceuticals Outperform | RBC Capital Markets | |
| 15.09.17 | Enanta Pharmaceuticals Outperform | RBC Capital Markets | |
| 07.08.15 | Enanta Pharmaceuticals Equal weight | Barclays Capital | |
| 06.04.15 | Enanta Pharmaceuticals Buy | Deutsche Bank AG | |
| 04.03.15 | Enanta Pharmaceuticals Equal weight | Barclays Capital |
Werbung
Werbung